iwNHL 2018

The 16th International Workshop on Non-Hodgkin Lymphoma (iwNHL) took place in Nice, France, from September 21–23, 2018.

This year’s meeting highlighted efforts to understand the biology of different NHL subtypes, as well as novel  therapeutic strategies to optimize clinical care.

As the iwNHL’s official media partner, VJHemOnc was there to cover this exciting new content.

1:33
CAR T-cell therapy: on the way to success
Steven Rosen
1:01
Nuances of systemic lymphoma and CNS lymphoma
Bianca Santomasso
1:09
Non-hodgkin lymphoma advances in 2018
Steven Rosen
2:09
CAR-T super users: teams to closely monitor patients receiving CAR T-cells
Bianca Santomasso
2:03
The challenging field of hem-onc therapeutics
Steven Rosen
2:15
Management of cytokine release syndrome and neurotoxicity: an emerging need
Bianca Santomasso
6:32
Pathobiology and clinical management of T-cell lymphoma
Francine Foss et al.
9:02
Precision medicine in lymphoma
Anas Younes et al.
9:57
Cellular therapy and drug access for viral lymphomas
Catherine Bollard et al.
8:24
Viral lymphomas: risk factors and treatments
Catherine Bollard et al.
8:01
Novel diagnostics & biomarkers for DLBCL and CTCL
Bjoern Chapuy et al.
7:43
Immunotherapy for NHL: checkpoint inhibitors, considerations & the future
John Gribben et al.
11:58
iwNHL day 2 highlights: bridging the gap to CAR T-cell therapy & precision medicine
Anas Younes et al.
12:32
iwNHL 2018 day 1 highlights: T-cells, biomarkers & personalized medicine
Catherine Bollard et al.
11:13
CAR T-cells in lymphoma: where are we now?
David Maloney et al.
7:45
Novel targets and agents for lymphoma
John Kuruvilla et al.
The content of VJHemOnc is intended for healthcare professionals